Last updated: April 17, 2025
Sponsor: Centre Hospitalier Universitaire de Nice
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Passage of olfactory tests
Clinical Study ID
NCT06386523
23-AOI-03
Ages 18-99 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Subjects > 18 years old
No olfactory complaints; subjective estimation of "normal" olfaction
Affiliated to the Social Security system
Signing of informed consent
Exclusion
Exclusion Criteria:
Parosmia/phantosmia, hyposmia/anosmia, pre-existing subjective dysgeusia/ageusia
ATCD of sinus or cranial neoplasia
ATCD of sinus or cranial radiotherapy
Neurological or neurodegenerative disease
ATCD of persistent post-viral hyposmia or anosmia (including COVID) (more than 3months)
Study Design
Total Participants: 112
Treatment Group(s): 1
Primary Treatment: Passage of olfactory tests
Phase:
Study Start date:
October 21, 2024
Estimated Completion Date:
March 25, 2025
Study Description
Connect with a study center
CH de Cannes
Cannes,
FranceSite Not Available
CHU de Nice
Nice,
FranceSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.